董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| 樊震 | 男 | CEO, Director and Chairman of the Board | 45 | 未披露 | 1727.00 | 2024-01-29 |
| Lei Xu | 男 | Chief Operating Officer and Director | 35 | 未披露 | 536.00 | 2024-01-29 |
| Jia Liu | 女 | Independent Director | 40 | 未披露 | 未持股 | 2024-01-29 |
| Changmao Su | 男 | Independent Director | 41 | 未披露 | 未持股 | 2024-01-29 |
| Jianbing Zhang | 男 | Independent Director | 44 | 未披露 | 未持股 | 2024-01-29 |
高管介绍
注：高管持股数取自最新公司公告
董事简历
中英对照 | 中文 | 英文- 樊震
-
樊震，自2022年8月起担任浩西健康科技有限公司董事，自2022年9月起担任浩西健康科技有限公司首席执行官，自2023年起担任浩西健康科技有限公司董事会主席。他在在线运营和营销行业拥有超过15年的经验。2000年3月至2008年5月，他担任搜狐有限公司的媒体专家，负责财务渠道的运营管理、内容建设和产品开发。2009年9月至2012年3月，他担任凤凰新媒体有限公司www.ifeng.com的内容总监，负责金融和科技房地产渠道的运营和管理，以及渠道建设。从2018年3月至2021年12月，他担任Mmtec, Inc.（纳斯达克上市公司：MTC）的首席执行董事，全面负责公司的业务发展，团队管理和资本运营。他自2022年8月起担任昊西北京总裁，主要负责公司的资本运营、融资并购和资源扩张。他在扬州大学获得自动化学士学位，在中国社会科学院研究生院获得金融学硕士学位。
Zhen Fan,has served as Haoxi Health Technology Limited director since August 2022, Haoxi Health Technology Limited CEO since September 2022, and Haoxi Health Technology Limited Chairman of the Board of Directors since October 16, 2023. Mr. Fan has over 15 years of experience in online operation and marketing industry. From March 2000 to May 2008, Mr. Fan served as a media specialist at Sohu.Com Limited, where he was responsible for the operation management, content construction, and product development of the financial channel. From September 2009 to March 2012, Mr. Fan served as the Director of Content at www.ifeng.com of Phoenix New Media Limited, where he was responsible for the operation and management of finance and technology real estate channel, as well as channel construction. From March 2018 to December 2021, Mr. Fan served as the Chief Executive Director of Mmtec, Inc. (NASDAQ: MTC), a public company listed on Nasdaq, where he was fully responsible for the company's business development, team management, and capital operation. Mr. Fan has served as Haoxi Beijing's President since August 2022, where he is mainly responsible for the company's capital operation, financing mergers and acquisitions, and resource expansion. Mr. Fan received his Bachelor's degree in electronic automation from Yangzhou University in Yangzhou, China. - 樊震，自2022年8月起担任浩西健康科技有限公司董事，自2022年9月起担任浩西健康科技有限公司首席执行官，自2023年起担任浩西健康科技有限公司董事会主席。他在在线运营和营销行业拥有超过15年的经验。2000年3月至2008年5月，他担任搜狐有限公司的媒体专家，负责财务渠道的运营管理、内容建设和产品开发。2009年9月至2012年3月，他担任凤凰新媒体有限公司www.ifeng.com的内容总监，负责金融和科技房地产渠道的运营和管理，以及渠道建设。从2018年3月至2021年12月，他担任Mmtec, Inc.（纳斯达克上市公司：MTC）的首席执行董事，全面负责公司的业务发展，团队管理和资本运营。他自2022年8月起担任昊西北京总裁，主要负责公司的资本运营、融资并购和资源扩张。他在扬州大学获得自动化学士学位，在中国社会科学院研究生院获得金融学硕士学位。
- Zhen Fan,has served as Haoxi Health Technology Limited director since August 2022, Haoxi Health Technology Limited CEO since September 2022, and Haoxi Health Technology Limited Chairman of the Board of Directors since October 16, 2023. Mr. Fan has over 15 years of experience in online operation and marketing industry. From March 2000 to May 2008, Mr. Fan served as a media specialist at Sohu.Com Limited, where he was responsible for the operation management, content construction, and product development of the financial channel. From September 2009 to March 2012, Mr. Fan served as the Director of Content at www.ifeng.com of Phoenix New Media Limited, where he was responsible for the operation and management of finance and technology real estate channel, as well as channel construction. From March 2018 to December 2021, Mr. Fan served as the Chief Executive Director of Mmtec, Inc. (NASDAQ: MTC), a public company listed on Nasdaq, where he was fully responsible for the company's business development, team management, and capital operation. Mr. Fan has served as Haoxi Beijing's President since August 2022, where he is mainly responsible for the company's capital operation, financing mergers and acquisitions, and resource expansion. Mr. Fan received his Bachelor's degree in electronic automation from Yangzhou University in Yangzhou, China.
- Lei Xu
-
Lei Xu自2023年2月起担任Haoxi Health Technology Limited的首席运营官，并将担任Haoxi Health Technology Limited的董事。Xu先生在医疗保健营销行业拥有超过10年的经验。从2012年1月至2013年11月，Xu先生担任公合电广公司湖北分公司的销售总监，公合电广公司湖北分公司与湖北省电视台合作进行媒体资源工作，他在那里组建并领导团队开发湖北省的医疗行业电视广告业务，创造了1.6亿元的年销售额。从2013年12月至2016年12月，Xu先生担任上海润宇文化有限公司的总经理，上海润宇文化有限公司与腾讯控股有限公司（“腾讯”）旗下的上海本地电视台合作进行医疗保健行业广告业务，他组建并领导团队开发上海本地医疗行业客户，为腾讯的上海本地电视台提供在线营销服务，并为腾讯大申网等医疗行业客户建立相关产品。从2017年1月至2018年3月，Xu先生担任文康集团有限公司寻医问药网药品事业部的商业化总经理，他整合平台资源，为制药行业客户制定商业产品，并确定行业政策。在寻医问药网，他组建了一支制药行业的业务拓展团队，制定销售策略，并开发行业客户，推动了制药行业市场客户数量和广告收入同比增长100%。Xu先生自2018年4月起担任Haoxi Beijing的创始人兼销售经理。Xu先生于2012年获得天津工程师范大学计算机科学与技术学士学位。
Lei Xu,has served as Haoxi Health Technology Limited Chief Operating Officer since February 2023 and has served as Haoxi Health Technology Limited director since January 2024. Mr. Xu has over 10 years of experience in healthcare marketing industry. From January 2012 to November 2013, Mr. Xu served as the Sales Director at Gonghedianguang Company Hubei Branch, a company works with Hubei Provincial Television in media resources, where he set up and led the team to develop the medical industry business of TV advertising in Hubei Province, creating annual sales of 160 million RMB. From December 2013 to December 2016, Mr. Xu served as the General Manager of Shanghai Runyu Culture Co., Ltd, a company works with Shanghai local station of Tencent Holdings Limited ("Tencent") in medical and healthcare industry advertising, where he set up and led a team to develop local medical industry customers in Shanghai, provided online marketing services for Tencent's Shanghai local station, and built related products for medical industry customers like Tencent Dashen Website. From January 2017 to March 2018, Mr. Xu served as the General Manager of Commercialization of Pharmaceutical Sector at Xunyiwenyao Website of Wenkang Group Co., Ltd, where he integrated platform resources, formulated commercial products for customers in the pharmaceutical industry, and determined industry policies. At Xunyiwenyao, he set up a business development team in the pharmaceutical industry, formulated sales strategies, and developed industry customers, promoting a 100% year-on-year increase in the number of market customers and advertising revenue in the pharmaceutical industry. Mr. Xu has served as Haoxi Beijing's founder and sales manager since April 2018. Mr. Xu received his Bachelor's degree in Computer Science and Technology from Tianjin Engineering Normal University in 2012. - Lei Xu自2023年2月起担任Haoxi Health Technology Limited的首席运营官，并将担任Haoxi Health Technology Limited的董事。Xu先生在医疗保健营销行业拥有超过10年的经验。从2012年1月至2013年11月，Xu先生担任公合电广公司湖北分公司的销售总监，公合电广公司湖北分公司与湖北省电视台合作进行媒体资源工作，他在那里组建并领导团队开发湖北省的医疗行业电视广告业务，创造了1.6亿元的年销售额。从2013年12月至2016年12月，Xu先生担任上海润宇文化有限公司的总经理，上海润宇文化有限公司与腾讯控股有限公司（“腾讯”）旗下的上海本地电视台合作进行医疗保健行业广告业务，他组建并领导团队开发上海本地医疗行业客户，为腾讯的上海本地电视台提供在线营销服务，并为腾讯大申网等医疗行业客户建立相关产品。从2017年1月至2018年3月，Xu先生担任文康集团有限公司寻医问药网药品事业部的商业化总经理，他整合平台资源，为制药行业客户制定商业产品，并确定行业政策。在寻医问药网，他组建了一支制药行业的业务拓展团队，制定销售策略，并开发行业客户，推动了制药行业市场客户数量和广告收入同比增长100%。Xu先生自2018年4月起担任Haoxi Beijing的创始人兼销售经理。Xu先生于2012年获得天津工程师范大学计算机科学与技术学士学位。
- Lei Xu,has served as Haoxi Health Technology Limited Chief Operating Officer since February 2023 and has served as Haoxi Health Technology Limited director since January 2024. Mr. Xu has over 10 years of experience in healthcare marketing industry. From January 2012 to November 2013, Mr. Xu served as the Sales Director at Gonghedianguang Company Hubei Branch, a company works with Hubei Provincial Television in media resources, where he set up and led the team to develop the medical industry business of TV advertising in Hubei Province, creating annual sales of 160 million RMB. From December 2013 to December 2016, Mr. Xu served as the General Manager of Shanghai Runyu Culture Co., Ltd, a company works with Shanghai local station of Tencent Holdings Limited ("Tencent") in medical and healthcare industry advertising, where he set up and led a team to develop local medical industry customers in Shanghai, provided online marketing services for Tencent's Shanghai local station, and built related products for medical industry customers like Tencent Dashen Website. From January 2017 to March 2018, Mr. Xu served as the General Manager of Commercialization of Pharmaceutical Sector at Xunyiwenyao Website of Wenkang Group Co., Ltd, where he integrated platform resources, formulated commercial products for customers in the pharmaceutical industry, and determined industry policies. At Xunyiwenyao, he set up a business development team in the pharmaceutical industry, formulated sales strategies, and developed industry customers, promoting a 100% year-on-year increase in the number of market customers and advertising revenue in the pharmaceutical industry. Mr. Xu has served as Haoxi Beijing's founder and sales manager since April 2018. Mr. Xu received his Bachelor's degree in Computer Science and Technology from Tianjin Engineering Normal University in 2012.
- Jia Liu
-
Jia Liu将立即担任Haoxi Health Technology Limited的独立董事。刘女士自2008年6月起担任瑞科荣信科技有限公司（Recon Technology Ltd）的首席财务官，并自2021年7月起担任该公司的董事。刘女士在美国市场融资方面拥有丰富的经验，并对美国通用会计准则（GAAP）、萨班斯-奥克斯利法案（Sarbanes Oxley）和公共部门法规有详细的了解。刘女士于2006年获得北京化工大学经济与管理学院的学士学位，并于2009年获得北京物资学院的工业经济学硕士学位。刘女士是一名持有美国注册会计师（CPA）资格认证的专业人士。
Jia Liu,has served as Haoxi Health Technology Limited independent director since January 2024. Ms. Liu serves as Chief Financial Officer of Recon Technology Ltd since June 2008 and director of Recon Technology Ltd since July 2021. Ms. Liu has rich experience of U.S. market financing and has detailed knowledge of U.S. GAAP, Sarbanes Oxley, and public sector regulations. Ms. Liu received her Bachelor's degree from Beijing University of Chemical and Technology, School of Economics and Management in 2006 and her Master's degree in industrial economics from Beijing Wuzi University in 2009. Ms. Liu is a certified U.S. CPA. - Jia Liu将立即担任Haoxi Health Technology Limited的独立董事。刘女士自2008年6月起担任瑞科荣信科技有限公司（Recon Technology Ltd）的首席财务官，并自2021年7月起担任该公司的董事。刘女士在美国市场融资方面拥有丰富的经验，并对美国通用会计准则（GAAP）、萨班斯-奥克斯利法案（Sarbanes Oxley）和公共部门法规有详细的了解。刘女士于2006年获得北京化工大学经济与管理学院的学士学位，并于2009年获得北京物资学院的工业经济学硕士学位。刘女士是一名持有美国注册会计师（CPA）资格认证的专业人士。
- Jia Liu,has served as Haoxi Health Technology Limited independent director since January 2024. Ms. Liu serves as Chief Financial Officer of Recon Technology Ltd since June 2008 and director of Recon Technology Ltd since July 2021. Ms. Liu has rich experience of U.S. market financing and has detailed knowledge of U.S. GAAP, Sarbanes Oxley, and public sector regulations. Ms. Liu received her Bachelor's degree from Beijing University of Chemical and Technology, School of Economics and Management in 2006 and her Master's degree in industrial economics from Beijing Wuzi University in 2009. Ms. Liu is a certified U.S. CPA.
- Changmao Su
-
Changmao Su将担任Haoxi Health Technology Limited独立董事。Su先生曾于2008年1月至2015年2月在北京搜狐新媒体信息技术有限公司担任产品经理，并于2015年3月至2020年6月担任伊斯互动（北京）科技有限公司的首席执行官。自2020年7月以来，他一直担任北京新氧科技有限公司的副总裁。他在医美消费领域拥有成功的创业经验，在线下和线上的Haoxi Health Technology Limited扩张方面拥有成熟的运营经验，并设计和运营过每日活跃Haoxi Health Technology Limited用户超过1000万的产品。Su先生于2005年获得北京大学生命科学与技术学士学位。
Changmao Su,has served as Haoxi Health Technology Limited independent director since January 2024. Mr. Su served as a product manager at Beijing Sohu New Media Information Technology Co. Ltd. from January 2008 to February 2015, and the CEO of Yisi Interactive (Beijing) Technology Co. Ltd. from March, 2015 to June, 2020. He has worked as vice president of Beijing New Oxygen Technology Co. Ltd. since July 2020. He has successful entrepreneurial experience in the field of medical beauty consumption, has mature operating experience in online and offline Haoxi Health Technology Limited er growth, and has designed and operated products with over 10 million daily active Haoxi Health Technology Limited ers. Mr. Su obtained his Bachelor's degree in Life Science and Technology from Peking University in 2005. - Changmao Su将担任Haoxi Health Technology Limited独立董事。Su先生曾于2008年1月至2015年2月在北京搜狐新媒体信息技术有限公司担任产品经理，并于2015年3月至2020年6月担任伊斯互动（北京）科技有限公司的首席执行官。自2020年7月以来，他一直担任北京新氧科技有限公司的副总裁。他在医美消费领域拥有成功的创业经验，在线下和线上的Haoxi Health Technology Limited扩张方面拥有成熟的运营经验，并设计和运营过每日活跃Haoxi Health Technology Limited用户超过1000万的产品。Su先生于2005年获得北京大学生命科学与技术学士学位。
- Changmao Su,has served as Haoxi Health Technology Limited independent director since January 2024. Mr. Su served as a product manager at Beijing Sohu New Media Information Technology Co. Ltd. from January 2008 to February 2015, and the CEO of Yisi Interactive (Beijing) Technology Co. Ltd. from March, 2015 to June, 2020. He has worked as vice president of Beijing New Oxygen Technology Co. Ltd. since July 2020. He has successful entrepreneurial experience in the field of medical beauty consumption, has mature operating experience in online and offline Haoxi Health Technology Limited er growth, and has designed and operated products with over 10 million daily active Haoxi Health Technology Limited ers. Mr. Su obtained his Bachelor's degree in Life Science and Technology from Peking University in 2005.
- Jianbing Zhang
-
Jianbing Zhang将担任Haoxi Health Technology Limited的独立董事。Zhang先生自2017年6月起担任中翰生态生物科技有限公司的总经理。他曾于2012年3月至2017年5月担任上海奥普生物制药有限公司的市场总监，以及2003年3月至2012年2月担任北京科力亚生物科技有限公司的总经理。Zhang先生在医疗器械行业拥有超过20年的专业经验。他对中国的医疗器械行业和医疗保健服务行业有着深入的了解。他于2016年获得上海交通大学工商管理硕士学位。
Jianbing Zhang,has served as Haoxi Health Technology Limited independent director since January 2024. Mr. Zhang has worked as the general manager of Zhonghan Shengtai Biotechnology Co., Ltd. since June 2017. He once served as a marketing director of Shanghai Aopu Bio-Pharmaceutical Co. Ltd. from March 2012 to May 2017 and the general manager of Beijing Keliya Bio-Tech Co. Ltd. from March 2003 to February 2012. Mr. Zhang has more than 20 years of professional experience in the medical device industry. He has a deep understanding of China's medical device industry and the healthcare service industry. He obtained his Master of Business Administration degree from Shanghai Jiao Tong University in 2016. - Jianbing Zhang将担任Haoxi Health Technology Limited的独立董事。Zhang先生自2017年6月起担任中翰生态生物科技有限公司的总经理。他曾于2012年3月至2017年5月担任上海奥普生物制药有限公司的市场总监，以及2003年3月至2012年2月担任北京科力亚生物科技有限公司的总经理。Zhang先生在医疗器械行业拥有超过20年的专业经验。他对中国的医疗器械行业和医疗保健服务行业有着深入的了解。他于2016年获得上海交通大学工商管理硕士学位。
- Jianbing Zhang,has served as Haoxi Health Technology Limited independent director since January 2024. Mr. Zhang has worked as the general manager of Zhonghan Shengtai Biotechnology Co., Ltd. since June 2017. He once served as a marketing director of Shanghai Aopu Bio-Pharmaceutical Co. Ltd. from March 2012 to May 2017 and the general manager of Beijing Keliya Bio-Tech Co. Ltd. from March 2003 to February 2012. Mr. Zhang has more than 20 years of professional experience in the medical device industry. He has a deep understanding of China's medical device industry and the healthcare service industry. He obtained his Master of Business Administration degree from Shanghai Jiao Tong University in 2016.
高管简历
中英对照 | 中文 | 英文- 樊震
樊震，自2022年8月起担任浩西健康科技有限公司董事，自2022年9月起担任浩西健康科技有限公司首席执行官，自2023年起担任浩西健康科技有限公司董事会主席。他在在线运营和营销行业拥有超过15年的经验。2000年3月至2008年5月，他担任搜狐有限公司的媒体专家，负责财务渠道的运营管理、内容建设和产品开发。2009年9月至2012年3月，他担任凤凰新媒体有限公司www.ifeng.com的内容总监，负责金融和科技房地产渠道的运营和管理，以及渠道建设。从2018年3月至2021年12月，他担任Mmtec, Inc.（纳斯达克上市公司：MTC）的首席执行董事，全面负责公司的业务发展，团队管理和资本运营。他自2022年8月起担任昊西北京总裁，主要负责公司的资本运营、融资并购和资源扩张。他在扬州大学获得自动化学士学位，在中国社会科学院研究生院获得金融学硕士学位。
Zhen Fan,has served as Haoxi Health Technology Limited director since August 2022, Haoxi Health Technology Limited CEO since September 2022, and Haoxi Health Technology Limited Chairman of the Board of Directors since October 16, 2023. Mr. Fan has over 15 years of experience in online operation and marketing industry. From March 2000 to May 2008, Mr. Fan served as a media specialist at Sohu.Com Limited, where he was responsible for the operation management, content construction, and product development of the financial channel. From September 2009 to March 2012, Mr. Fan served as the Director of Content at www.ifeng.com of Phoenix New Media Limited, where he was responsible for the operation and management of finance and technology real estate channel, as well as channel construction. From March 2018 to December 2021, Mr. Fan served as the Chief Executive Director of Mmtec, Inc. (NASDAQ: MTC), a public company listed on Nasdaq, where he was fully responsible for the company's business development, team management, and capital operation. Mr. Fan has served as Haoxi Beijing's President since August 2022, where he is mainly responsible for the company's capital operation, financing mergers and acquisitions, and resource expansion. Mr. Fan received his Bachelor's degree in electronic automation from Yangzhou University in Yangzhou, China.- 樊震，自2022年8月起担任浩西健康科技有限公司董事，自2022年9月起担任浩西健康科技有限公司首席执行官，自2023年起担任浩西健康科技有限公司董事会主席。他在在线运营和营销行业拥有超过15年的经验。2000年3月至2008年5月，他担任搜狐有限公司的媒体专家，负责财务渠道的运营管理、内容建设和产品开发。2009年9月至2012年3月，他担任凤凰新媒体有限公司www.ifeng.com的内容总监，负责金融和科技房地产渠道的运营和管理，以及渠道建设。从2018年3月至2021年12月，他担任Mmtec, Inc.（纳斯达克上市公司：MTC）的首席执行董事，全面负责公司的业务发展，团队管理和资本运营。他自2022年8月起担任昊西北京总裁，主要负责公司的资本运营、融资并购和资源扩张。他在扬州大学获得自动化学士学位，在中国社会科学院研究生院获得金融学硕士学位。
- Zhen Fan,has served as Haoxi Health Technology Limited director since August 2022, Haoxi Health Technology Limited CEO since September 2022, and Haoxi Health Technology Limited Chairman of the Board of Directors since October 16, 2023. Mr. Fan has over 15 years of experience in online operation and marketing industry. From March 2000 to May 2008, Mr. Fan served as a media specialist at Sohu.Com Limited, where he was responsible for the operation management, content construction, and product development of the financial channel. From September 2009 to March 2012, Mr. Fan served as the Director of Content at www.ifeng.com of Phoenix New Media Limited, where he was responsible for the operation and management of finance and technology real estate channel, as well as channel construction. From March 2018 to December 2021, Mr. Fan served as the Chief Executive Director of Mmtec, Inc. (NASDAQ: MTC), a public company listed on Nasdaq, where he was fully responsible for the company's business development, team management, and capital operation. Mr. Fan has served as Haoxi Beijing's President since August 2022, where he is mainly responsible for the company's capital operation, financing mergers and acquisitions, and resource expansion. Mr. Fan received his Bachelor's degree in electronic automation from Yangzhou University in Yangzhou, China.
- Bo Lyu
Bo Lyu，自2023年2月起担任Haoxi Health Technology Limited首席财务官。他在企业融资和上市公司管理方面拥有超过10年的经验。从2021年11月起，他担任Heyu Biological Technology Corporation的首席财务官。从2020年8月到2021年10月，他担任Building Dreamstar Technology Inc.的财务总监。2017年12月至2019年4月，他担任Dragon Victory International Limited （NASDAQ： LYL）的董事会秘书。2014年1月至2017年8月，他担任海亮教育集团有限公司（纳斯达克股票代码：HLG）的董事会秘书。2009年7月至2013年12月，他曾担任海亮集团有限公司（海亮教育集团有限公司当时的母公司）、浙江海亮股份有限公司（上海证券交易所代码：002203）和海亮国际控股有限公司（香港证券交易所代码：02336）的投资经理。他于2001年获得武汉大学国际投资学士学位，并于2008年获得阿尔伯特-路德维希-弗莱堡大学国家经济系金融硕士学位。他还持有深圳证券交易所董事会秘书证书，是CFA II候选人。
Bo Lyu,has served as Haoxi Health Technology Limited Chief Financial Officer since February 2023. Mr. Lyu has over 10 years of experience in corporate financing and public company management. From November 2021, Mr. Lyu has served as the Chief Financial Officer of Heyu Biological Technology Corporation. From August 2020 to October 2021, Mr. Lyu served as a financial controller of Building Dreamstar Technology Inc. From December 2017 to April 2019, Mr. Lyu served as the board secretary of Dragon Victory International Limited (NASDAQ: LYL). From January 2014 to August 2017, Mr. Lyu served as the board secretary of Hailiang Education Group Inc. (NASDAQ: HLG). From July 2009 to December 2013, Mr. Lyu worked as an investment manager at Hailiang Group Co. Ltd., the then-parent company of Hailiang Education Group Inc., Zhejiang Hailiang Co. Ltd. (SSE: 002203), and Hailiang International Holding Co. Ltd. (HKSE: 02336). Mr. Lyu received his Bachelor's degree in International Investment from Wuhan University in 2001, and his Master's degree in Finance from the National Economics Department of Albert-Ludwigs-Universitt Freiburg in 2008. He also holds the Certificate of Board Secretary from Shenzhen Stock Exchange and is a CFA II candidate.- Bo Lyu，自2023年2月起担任Haoxi Health Technology Limited首席财务官。他在企业融资和上市公司管理方面拥有超过10年的经验。从2021年11月起，他担任Heyu Biological Technology Corporation的首席财务官。从2020年8月到2021年10月，他担任Building Dreamstar Technology Inc.的财务总监。2017年12月至2019年4月，他担任Dragon Victory International Limited （NASDAQ： LYL）的董事会秘书。2014年1月至2017年8月，他担任海亮教育集团有限公司（纳斯达克股票代码：HLG）的董事会秘书。2009年7月至2013年12月，他曾担任海亮集团有限公司（海亮教育集团有限公司当时的母公司）、浙江海亮股份有限公司（上海证券交易所代码：002203）和海亮国际控股有限公司（香港证券交易所代码：02336）的投资经理。他于2001年获得武汉大学国际投资学士学位，并于2008年获得阿尔伯特-路德维希-弗莱堡大学国家经济系金融硕士学位。他还持有深圳证券交易所董事会秘书证书，是CFA II候选人。
- Bo Lyu,has served as Haoxi Health Technology Limited Chief Financial Officer since February 2023. Mr. Lyu has over 10 years of experience in corporate financing and public company management. From November 2021, Mr. Lyu has served as the Chief Financial Officer of Heyu Biological Technology Corporation. From August 2020 to October 2021, Mr. Lyu served as a financial controller of Building Dreamstar Technology Inc. From December 2017 to April 2019, Mr. Lyu served as the board secretary of Dragon Victory International Limited (NASDAQ: LYL). From January 2014 to August 2017, Mr. Lyu served as the board secretary of Hailiang Education Group Inc. (NASDAQ: HLG). From July 2009 to December 2013, Mr. Lyu worked as an investment manager at Hailiang Group Co. Ltd., the then-parent company of Hailiang Education Group Inc., Zhejiang Hailiang Co. Ltd. (SSE: 002203), and Hailiang International Holding Co. Ltd. (HKSE: 02336). Mr. Lyu received his Bachelor's degree in International Investment from Wuhan University in 2001, and his Master's degree in Finance from the National Economics Department of Albert-Ludwigs-Universitt Freiburg in 2008. He also holds the Certificate of Board Secretary from Shenzhen Stock Exchange and is a CFA II candidate.
- Lei Xu
Lei Xu自2023年2月起担任Haoxi Health Technology Limited的首席运营官，并将担任Haoxi Health Technology Limited的董事。Xu先生在医疗保健营销行业拥有超过10年的经验。从2012年1月至2013年11月，Xu先生担任公合电广公司湖北分公司的销售总监，公合电广公司湖北分公司与湖北省电视台合作进行媒体资源工作，他在那里组建并领导团队开发湖北省的医疗行业电视广告业务，创造了1.6亿元的年销售额。从2013年12月至2016年12月，Xu先生担任上海润宇文化有限公司的总经理，上海润宇文化有限公司与腾讯控股有限公司（“腾讯”）旗下的上海本地电视台合作进行医疗保健行业广告业务，他组建并领导团队开发上海本地医疗行业客户，为腾讯的上海本地电视台提供在线营销服务，并为腾讯大申网等医疗行业客户建立相关产品。从2017年1月至2018年3月，Xu先生担任文康集团有限公司寻医问药网药品事业部的商业化总经理，他整合平台资源，为制药行业客户制定商业产品，并确定行业政策。在寻医问药网，他组建了一支制药行业的业务拓展团队，制定销售策略，并开发行业客户，推动了制药行业市场客户数量和广告收入同比增长100%。Xu先生自2018年4月起担任Haoxi Beijing的创始人兼销售经理。Xu先生于2012年获得天津工程师范大学计算机科学与技术学士学位。
Lei Xu,has served as Haoxi Health Technology Limited Chief Operating Officer since February 2023 and has served as Haoxi Health Technology Limited director since January 2024. Mr. Xu has over 10 years of experience in healthcare marketing industry. From January 2012 to November 2013, Mr. Xu served as the Sales Director at Gonghedianguang Company Hubei Branch, a company works with Hubei Provincial Television in media resources, where he set up and led the team to develop the medical industry business of TV advertising in Hubei Province, creating annual sales of 160 million RMB. From December 2013 to December 2016, Mr. Xu served as the General Manager of Shanghai Runyu Culture Co., Ltd, a company works with Shanghai local station of Tencent Holdings Limited ("Tencent") in medical and healthcare industry advertising, where he set up and led a team to develop local medical industry customers in Shanghai, provided online marketing services for Tencent's Shanghai local station, and built related products for medical industry customers like Tencent Dashen Website. From January 2017 to March 2018, Mr. Xu served as the General Manager of Commercialization of Pharmaceutical Sector at Xunyiwenyao Website of Wenkang Group Co., Ltd, where he integrated platform resources, formulated commercial products for customers in the pharmaceutical industry, and determined industry policies. At Xunyiwenyao, he set up a business development team in the pharmaceutical industry, formulated sales strategies, and developed industry customers, promoting a 100% year-on-year increase in the number of market customers and advertising revenue in the pharmaceutical industry. Mr. Xu has served as Haoxi Beijing's founder and sales manager since April 2018. Mr. Xu received his Bachelor's degree in Computer Science and Technology from Tianjin Engineering Normal University in 2012.- Lei Xu自2023年2月起担任Haoxi Health Technology Limited的首席运营官，并将担任Haoxi Health Technology Limited的董事。Xu先生在医疗保健营销行业拥有超过10年的经验。从2012年1月至2013年11月，Xu先生担任公合电广公司湖北分公司的销售总监，公合电广公司湖北分公司与湖北省电视台合作进行媒体资源工作，他在那里组建并领导团队开发湖北省的医疗行业电视广告业务，创造了1.6亿元的年销售额。从2013年12月至2016年12月，Xu先生担任上海润宇文化有限公司的总经理，上海润宇文化有限公司与腾讯控股有限公司（“腾讯”）旗下的上海本地电视台合作进行医疗保健行业广告业务，他组建并领导团队开发上海本地医疗行业客户，为腾讯的上海本地电视台提供在线营销服务，并为腾讯大申网等医疗行业客户建立相关产品。从2017年1月至2018年3月，Xu先生担任文康集团有限公司寻医问药网药品事业部的商业化总经理，他整合平台资源，为制药行业客户制定商业产品，并确定行业政策。在寻医问药网，他组建了一支制药行业的业务拓展团队，制定销售策略，并开发行业客户，推动了制药行业市场客户数量和广告收入同比增长100%。Xu先生自2018年4月起担任Haoxi Beijing的创始人兼销售经理。Xu先生于2012年获得天津工程师范大学计算机科学与技术学士学位。
- Lei Xu,has served as Haoxi Health Technology Limited Chief Operating Officer since February 2023 and has served as Haoxi Health Technology Limited director since January 2024. Mr. Xu has over 10 years of experience in healthcare marketing industry. From January 2012 to November 2013, Mr. Xu served as the Sales Director at Gonghedianguang Company Hubei Branch, a company works with Hubei Provincial Television in media resources, where he set up and led the team to develop the medical industry business of TV advertising in Hubei Province, creating annual sales of 160 million RMB. From December 2013 to December 2016, Mr. Xu served as the General Manager of Shanghai Runyu Culture Co., Ltd, a company works with Shanghai local station of Tencent Holdings Limited ("Tencent") in medical and healthcare industry advertising, where he set up and led a team to develop local medical industry customers in Shanghai, provided online marketing services for Tencent's Shanghai local station, and built related products for medical industry customers like Tencent Dashen Website. From January 2017 to March 2018, Mr. Xu served as the General Manager of Commercialization of Pharmaceutical Sector at Xunyiwenyao Website of Wenkang Group Co., Ltd, where he integrated platform resources, formulated commercial products for customers in the pharmaceutical industry, and determined industry policies. At Xunyiwenyao, he set up a business development team in the pharmaceutical industry, formulated sales strategies, and developed industry customers, promoting a 100% year-on-year increase in the number of market customers and advertising revenue in the pharmaceutical industry. Mr. Xu has served as Haoxi Beijing's founder and sales manager since April 2018. Mr. Xu received his Bachelor's degree in Computer Science and Technology from Tianjin Engineering Normal University in 2012.